Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed

Can Fam Physician. 2012 Aug;58(8):850-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use
  • Dabigatran
  • Decision Support Techniques*
  • Health Status Indicators
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control*
  • Humans
  • Morpholines / adverse effects
  • Morpholines / therapeutic use
  • Practice Guidelines as Topic
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use
  • Pyridones / adverse effects
  • Pyridones / therapeutic use
  • Risk Assessment
  • Rivaroxaban
  • Stroke / etiology
  • Stroke / prevention & control*
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use
  • Warfarin / adverse effects
  • Warfarin / therapeutic use
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridones
  • Thiophenes
  • beta-Alanine
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Dabigatran